Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany

Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany

Abstract Background Inclusion body myositis (IBM) is the most frequent type of myositis in elder patients with a slow chronic progression and refractory to treatment. Previous cost of illness (COI) studies in IBM used claims data to estimate direct costs in the US. No evidence exists globally on bot...

Full description

Bibliographic Details
Main Authors: Katja C. Senn, Simone Thiele, Karsten Kummer, Maggie C. Walter, Klaus H. Nagels
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Inclusion body myositis
Cost of illness
Direct costs
Indirect costs
Informal care costs
Neuromuscular disease
Online Access:https://doi.org/10.1186/s13023-023-02902-3

Similar Items

Similar Items